NCT03216733Active, not recruiting
SORT OUT X - Combo Stent Versus ORSIRO Stent
Randomized Clinical Comparison of a Combined Sirolimus Eluting and Endothelial Progenitor Cell COMBO Stent With a Sirolimus-eluting OSIRO Stent in Patients Treated With Percutaneous Coronary Intervention - The SORT-OUT X Study
Source: ClinicalTrials.gov · Last updated 28 Nov 2023
Brief summary (registry, in English)
The aim of the Danish Organisation for randomised trials with clinical outcome (SORT OUT) is to compare the safety and efficacy of the ComboTM stent and Orsiro™ stent in the treatment of unselected patients with ischemic heart disease, using registry detection of clinically driven events.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 3148 (actual)
- First submitted
- 4 Jul 2017
- Start date
- 1 Jun 2017
- Primary completion date
- 30 Nov 2018
- Lead sponsor
- Aarhus University Hospital Skejby
- Diseases
- Coronary artery disease
- NCT number
- NCT03216733
What you commit to
- Study type: Interventional
- Participants enrolled: 3148
- From 1 Jun 2017 to the primary completion date, 30 Nov 2018
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergic to aspirin, clopidogrel, prasugrel or ticagrelor
- Allergic to sirolimus
Age
- Age \< 18 years
Other
- The patient does not wish to participate
- The patient is not able to consent to randomization (eg intubated patients)
- The patient do not speak Danish
- The patient is already included in this study
- The patient is already participating in other stent studies
- Life expectancy \<1 year
Who the study is looking for
- All patients aged ≥18 years who are eligible for treatment with one or several drug-eluting coronary stents at Rigshospitalet or one of the three heart centers in Aarhus, Odense and Aalborg can be included in the study.
- The patients will be treated in accordance with the criteria applicable at the individual sites.
- The investigators plan to include 3,140 patients.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aalborg University Hospital, Department of Cardiology Coordinator of this site? Confirm its status | Aalborg | Denmark | Unknown status |
| Aarhus University Hospital Skejby Coordinator of this site? Confirm its status | Aarhus N | Denmark | Unknown status |
| Rigshospitalet, Hjertecentret Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
| Odense Unversity Hospital, Department of Cardiology Coordinator of this site? Confirm its status | Odense C | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.